Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-24-030053
Filing Date
2024-04-04
Accepted
2024-04-04 06:30:39
Documents
123
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT ea0202988-10k_biomx.htm   iXBRL 10-K 1641334
2 DESCRIPTION OF SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EX ea020298801ex4-1_biomx.htm EX-4.1 32015
3 FORM OF INDEMNIFICATION AGREEMENT ea020298801ex10-3_biomx.htm EX-10.3 77487
4 EXCLUSIVE LICENSE BETWEEN ADAPTIVE PHAGE THERAPEUTICS, INC. AND UNITED STATES OF ea020298801ex10-22_biomx.htm EX-10.22 83029
5 FIRST AMENDMENT, DATED JANUARY 10, 2019, TO EXCLUSIVE LICENSE BETWEEN ADAPTIVE P ea020298801ex10-23_biomx.htm EX-10.23 14845
6 NON-EXCLUSIVE LICENSE AGREEMENT BY AND BETWEEN ADAPTIVE PHAGE THERAPEUTICS, INC. ea020298801ex10-24_biomx.htm EX-10.24 78243
7 LICENSE MODIFICATION 1, DATED AUGUST 31, 2022, TO NON-EXCLUSIVE LICENSE AGREEMEN ea020298801ex10-25_biomx.htm EX-10.25 13922
8 LEASE AGREEMENT, DATED AS OF AUGUST 9, 2019, BY AND BETWEEN ARE-708 QUINCE ORCHA ea020298801ex10-28_biomx.htm EX-10.28 261221
9 AMENDMENT NO. 1, DATED AS OF OCTOBER 28, 2020, TO LEASE AGREEMENT BY AND BETWEEN ea020298801ex10-29_biomx.htm EX-10.29 50210
10 AMENDMENT NO. 2, DATED AS OF JULY 8, 2021, TO LEASE AGREEMENT BY AND BETWEEN ARE ea020298801ex10-30_biomx.htm EX-10.30 51913
11 AMENDMENT NO. 3, DATED AS OF JULY 15, 2021, TO LEASE AGREEMENT BY AND BETWEEN AR ea020298801ex10-31_biomx.htm EX-10.31 40129
12 AMENDMENT NO. 4, DATED AS OF SEPTEMBER 27, 2022, TO LEASE AGREEMENT BY AND BETWE ea020298801ex10-32_biomx.htm EX-10.32 40477
13 AMENDMENT NO. 5, DATED AS OF FEBRUARY 2, 2023, TO LEASE AGREEMENT BY AND BETWEEN ea020298801ex10-33_biomx.htm EX-10.33 18005
14 AMENDMENT NO. 6, DATED AS OF MARCH 5, 2024, TO LEASE AGREEMENT BY AND BETWEEN AR ea020298801ex10-34_biomx.htm EX-10.34 165721
15 SUBSIDIARIES OF COMPANY ea020298801ex21-1_biomx.htm EX-21.1 1990
16 CONSENT OF KESSELMAN & KESSELMAN, CERTIFIED PUBLIC ACCOUNTANTS (ISR.), A MEMBER ea020298801ex23-1_biomx.htm EX-23.1 2327
17 CERTIFICATION ea020298801ex31-1_biomx.htm EX-31.1 16481
18 CERTIFICATION ea020298801ex31-2_biomx.htm EX-31.2 16416
19 CERTIFICATION ea020298801ex32-1_biomx.htm EX-32.1 9054
20 CLAWBACK POLICY ea020298801ex97-1_biomx.htm EX-97.1 40273
21 RESOLUTIONS OF BOARD OF DIRECTORS RATIFYING STOCK ISSUANCE ea020298801ex99-1_biomx.htm EX-99.1 7639
27 GRAPHIC image_001.jpg GRAPHIC 38645
28 GRAPHIC logo_001.jpg GRAPHIC 5332
29 GRAPHIC ex10-24_001.jpg GRAPHIC 4185
30 GRAPHIC ex10-24_002.jpg GRAPHIC 2404
31 GRAPHIC ex10-24_004.jpg GRAPHIC 1350
32 GRAPHIC ex10-24_005.jpg GRAPHIC 2151
33 GRAPHIC ex10-24_006.jpg GRAPHIC 8274
34 GRAPHIC ex10-25_001.jpg GRAPHIC 5294
35 GRAPHIC ex10-25_002.jpg GRAPHIC 3444
  Complete submission text file 0001213900-24-030053.txt   8967573

Data Files

Seq Description Document Type Size
22 XBRL CALCULATION FILE phge-20231231_cal.xml EX-101.CAL 56609
23 XBRL DEFINITION FILE phge-20231231_def.xml EX-101.DEF 368528
24 XBRL LABEL FILE phge-20231231_lab.xml EX-101.LAB 645774
25 XBRL PRESENTATION FILE phge-20231231_pre.xml EX-101.PRE 363249
26 XBRL SCHEMA FILE phge-20231231.xsd EX-101.SCH 86581
127 EXTRACTED XBRL INSTANCE DOCUMENT ea0202988-10k_biomx_htm.xml XML 682687
Mailing Address 22 EINSTEIN ST., 4TH FLOOR NESS ZIONA L3 7414003
Business Address 22 EINSTEIN ST., 4TH FLOOR NESS ZIONA L3 7414003 (972) 72 394 2377
BiomX Inc. (Filer) CIK: 0001739174 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38762 | Film No.: 24821575
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)